• For the second consecutive year, our  University was positioned in the third place of the largest national patent requests prepared by the National Industrial Property Institute (INAPI,  in Spanish). Dr. Louis Magne,  director of the Department of Technology Management, attended the awards ceremony  and he highlighted the efforts of the University to generate technological innovations.

Our University has managed to gradually increase the protection of intellectual property of the technologies  generated through its research and development. In 2011 it presented a total of 28 requests  at national and  international levels and through the Cooperation Treaty about Patenting Matters (PCT, in Spanish).

The number of nine national patent records required in 2011, helped to put the University in third place, according to the "INAPI Report 2012". The leader of this ranking was Universidad de  Concepción and P. Pontificia Universidad Católica, with a total number of thirteen requests for inventions each.

The award ceremony for this important achievement was held last Thursday in the new premises of INAPI and was chaired by Tomás Flores the Vice Secretary of Economics, and Maximiliano Santa Cruz, INAPI director.  Dr. Louis Magne, director of the Department of Technology Management from the office of Research and Development attended the ceremony and  represented our University. He  noted that patenting is a priority for the institution.

"The University has an important increase of the research that has  potential for new businesses, and this has allowed  the  identification of the results that might get a patent and which are the basis of innovative technologies that could be transferred to the productive sector," he said.

Throughout its history, the  Universidad de Santiago de Chile has presented 63 requests  for national patents. At the international level, it has presented 50 requests  in various countries, mostly in the United States. Of the total applications, 28 patents have been given, eleven  in Chilean territory, three in the U.S. and the rest in other countries.

"We are currently working to achieve that these patents generate licenses and then royalties, meeting  the challenge that Chile has about becoming a generator of technology," Magne explained.

What is the meaning of patenting?

A patent is an exclusive right granted by the State for the protection of an invention, so it recognizes and guarantees the exclusive commercial exploitation for the holder of the invention, thus preventing others from appropriating the benefits involved in its exploitation.

Obtaining these patents in the University is paramount as it demonstrates the ability to generate appropriable knowledge, and states the basis of technological products that have a future to contribute to the country and become  part of  the national and international markets.

To achieve this, the Technology Management Department is responsible for encouraging researchers to conduct applied research projects whose results are evaluated in its appropriability and evaluated for their further development, until the patent is generated.

The patents that are requested belong to the University, with the recognition of the authorship  for the inventors. If the invention is commercialized, 50 percent is for the group of researchers that  generates the patent and the remaining 50 percent for the University.

• Patricio Flores, PhD in Biotechnology, and Yu-Wen Tang, student at the Master´s program in Technology Management- Major in Biotechnology, both from the Faculty of Chemistry and Biology, were awarded a grant to develop a strategy for marketing an enzyme that has multiple benefits for diagnosing diseases.

As a result of the work they did for a doctoral dissertation and after being granted funds through the “Go To Market, de la Idea al Mercado” Contest organized by Corfo (the Chilean Economic Development Agency), the researchers will get trained in Silicon Valley, in the context of the third stage of the project “Developing a strategy for marketing a highly stable glutamate dehydrogenase (GLDH) enzyme.”

The project, which was developed under the guidance of Dr. Jenny Blamey, associate professor at Universidad de Santiago, proposes replacing the bovine GLDH enzyme with one from an Antarctic extremophilic microorganism (capable of resisting extreme conditions of temperature, pH, pressure, salinity, among others), which does not have the deficiencies of its predecessor. Its most common application is in the area of clinical laboratories where it is used for diagnosing hepatic and renal diseases

According to researcher Patricio Flores, “having discovered this new enzyme, glutamate dehydrogenase (GLDH), improves the half-life of five different types of diagnostic kits, as its thermal stability is higher than the one of the enzyme used today.” The academic stresses that “what is most important is that it also solves the problem of low half-life of the “old” diagnostic kits, preventing from discarding expired kits that have not been used, improving result reliability, lowering costs, reducing losses for companies and enabling a stock available to give a quick answer to market requirements.”

“The new enzyme is much more stable. It can be stored at room temperature, keeping more than 85% of its activity for 50 days. On the other hand, the bovine enzyme completely loses its activity under the same conditions,” Dr. Flores explains, regarding the results of this project that involves Universidad de Santiago and Fundación Científica y Cultural Biocencia.

Go To Market

“Go To Market, de la Idea al Mercado” is an initiative that seeks to identify research studies conducted at universities, technological centers and Chilean companies that have generated technologies that could potentially benefit the global market.

“The application process for the Corfo’s Go to Market Contest coincided with the last steps to finish my doctoral dissertation in which I developed the product prototype, that is to say, the GLDH enzyme from an Antarctic thermophilic microorganism,” Dr, Flores says.

At present, the project is at its third stage, which involves getting training at the Standford Research Institute (SRI), scheduling meetings with investors and interested clients and developing a marketing strategy to position the product in the market. These will be the activities that the two researchers will have while they stay in USA.

Translated by Marcela Contreras

• By means of a Regular Fondecyt Project, a research team at the Faculty of Chemistry and Biology led by Dr. Manuel Azócar is currently working on the optimization of compounds derived from silver, by adding them anti-inflammatory properties and higher thermal stability and durability for their future use as antibacterial agents.

Besides being a metal used in jewelry, silver has varied applications and properties. One of them is its high electrical conductivity. Another distinctive feature of this element is that its particles are used in creams to treat burns and warts; water purification systems; anti-microbial paints and anti-bacterial compounds.

Regarding this last application, Dr. Manuel Azócar, researcher at the Faculty of Chemistry and Biology of Universidad de Santiago de Chile, is developing new silver-based anti-bacterial agents with anti-inflammatory properties, by means of a Regular Fondecyt Project.

The main objective of this research is to understand and enhance the essential features of these compounds for their future use as broad-spectrum bactericidal agents, with more air and light stability.

“We are interested in optimizing these metallo pharmaceutical agents by adding them higher anti-inflammatory properties, higher thermal stability under light conditions and also in identifying the elements that may have toxic effects on cells,” the researcher said.

Besides, one of the most novel aspects of this study is that it seeks to optimize these compounds to use them in lower doses and give them more air and light stability, because silver is a sensitive metal and gets oxidized easily, getting darker in a short period of time.

At a first stage, the work team has been able to prepare several compounds that have made possible to understand the conditions that allow obtaining more stable and durable products. They have also been able to evaluate these compounds as anti-bacterial agents.

“As of 2015, we have planned to assess the cytotoxicity of these compounds, verify our hypotheses regarding the reduction of toxic effects and make a more detailed analysis of their structural features,” the researcher finally said.

Translated by Marcela Contreras

·         The drugs we use are delivered into our bodies in a short time because they are designed to be adsorbed at the intake and to lose effect some time later. In this field, the first results of a study at Universidad de Santiago are very valuable. The research team looked for an “intelligent” drug-delivery system; i.e. a system for a sustained release of the required dose to increase the drug efficacy. 

To understand the mechanisms that would allow in the future releasing drugs in the best place and at the best time, was one of the goals of the study led by Dr Eduardo Lissi, professor at the Faculty of Chemistry and Biology.

Nowadays, the drugs we use are delivered into our bodies in a short time; i.e., they are designed to be adsorbed at the intake and to lose effect some time later.

The purpose of the study was to understand the factors and cellular processes involved in this type of mechanism and Dr Eduardo Lissi, researcher at Universidad de Santiago, together with the Protein Research Group of the Faculty of Biology of Universidad de la Habana (Cuba) and researchers Alexis Aspee (Universidad de Santiago) and Marco Antonio Soto (Pontificia Universidad Católica de Chile), undertook the project.

“I think this is very interesting: designing “intelligent” systems for a particular effect, placing the carrier in the right place to control there the delivery of the bio-active species,” he says.

He adds that he is very “impressed for the magnitude of the problem and for having the possibility of connecting basic biophysics with its applications, particularly with those related to the potential for elaborating specific drugs especially for a given system.”

According to Dr Lissi, these “intelligent” systems would offer advantages in their application, like designing drugs that are released, “for example, when the host reaches a given temperature and/or a given osmotic gradient.” This would assure a sustained delivery of the dose of the required drug and increase its efficacy.

Another aspect of the study, which is still being worked on, is related to the ability of haemolytic toxins to generate channels that contribute to control cell damage. “This involves and interesting potential to selectively kill cell groups that you want to eradicate,” Dr Lissi says. The name of the project was Fondecyt 1130867, “Studies on the diffusion of small solutes through lipids bilayers in unilamellar liposomes."

Translated by Marcela Contreras

• Researchers at CECTA and DECYTAL at Universidad de Santiago successfully participated in two important scientific gatherings. They were the only Chileans participating in the 27^th International Conference on Yeast Genetics and Molecular Biology and the 02^nd International Specialized Symposium of Yeasts, held in the Italian cities of Levico and Perugia, respectively. Dr Verónica García Mena, Dr Claire Brice, Dr Claudio Martínez Fernández and Dr Francisco Cubillos Riffo presented their works at these conferences.

   

  Researchers at the Food Science and Technology Research Center (CECTA, in Spanish) and the Department of Food Science and Technology (DECYTAL, in Spanish) of Universidad de Santiago were the only Chilean representatives in two important scientific activities held in September, in Italy.

  The team led by Dr Claudio Martínez Fernández and made up of Dr Francisco Cubillos Riffo, Dr Verónica García Mena, and Dr Claire Brice presented the results of different studies conducted at the Applied Biotechnology and Microbiology Laboratory.

  The researchers participated in the 27^th International Conference on Yeast Genetics and Molecular Biology, held between September 06^th and 12^th, in Levico, and the 02^nd International Specialized Symposium of Yeasts, held between September 13^th and 17^th in Perugia, Italy.

  Strengthening links

  The director of CECTA, Dr Claudio Martínez, who is currently on a scientific-cultural exchange at the Instituto de Agroquímica y Tecnología de Alimentos (IATA, in Spanish) in Valencia, Spain, explained that the importance of these conferences lies on the possibility of “Strengthening links with the best researchers in this field worldwide, strengthening joint projects and opening opportunities to new collaborations and projects, as well as evaluating the level and the significance of what we are doing in Chile, that it is certainly very good at an international level.”

  For example, the team of CECTA is working on an international collaboration project with researchers at the IATA that also involves Argentinean researchers. And there is another international project with a French team that also participated in these conferences. This team is collaborating with a Fondecyt postdoctoral project and Dr Claire Brice is in charge of the last phase of this study.

  It is worth to mention that CECTA researchers were the only Chilean representatives in both conferences. According to professor Martínez, this was a surprise. And they were more surprised when they realized that, at a Latin American level, there were a few researchers from Argentina, Brazil and Uruguay. “This places us in a leading position at a national level and allows us to strengthen links with Latin American experts in this field to promote local and regional development,” he said.

  Leaders in yeast studies

  Yeasts were the common denominator in the conferences in which Universidad de Santiago researchers participated. Our university is leader in the area of yeast biotechnology in the country. “In this regard, the contributions made by our institution have turned into products (some of them have already been transferred to the productive sector in Chile and abroad) and specialized human resource training and have generated a worldwide renowned group of experts,” he concluded.

   

  Translated by Marcela Contreras

• With the funding of a Fondecyt Postdoctoral Project 2016, Dr Baptiste Darbois, professor at the Faculty of Science of Universidad de Santiago, will be able to accurately determine how lizards move in granular soils in order to produce results that allow to create a robot able to move easily in different types of soil.

With the funding of a Fondecyt Postdoctoral Project 2016, Dr Baptiste Darbois, professor at the Faculty of Science of Universidad de Santiago, will be able to accurately determine how lizards move in granular soils in order to produce results that allow to create a robot able to move easily in different types of soil. This would mean a significant contribution to robotics.

Based on previous research that found that once lizards dive in the sand, they move by wriggling their bodies and not by using their legs, Dr Darbois will study the interaction between a vibrating elastic structure and the granular environment.

The Fondecyt Postdoctoral project (3160167) is called “Locomoción ondulatoria de nadadores suaves dentro de los medios granulares.”

Experimental challenge

The experimental challenge of the study is to control the movement of grains and the forces they undergo when lizards move. This would help to establish guidelines for developing robots able to adapt themselves to different environments. The way of moving of different animals has inspired engineers in this field.

“We expect the compression produced by lizards’ undulating movements in the desert’s sub-surface to help us to develop efficient robots by incorporating this mechanism,” Dr Darbois explained.

Likewise, professor Darbois intends to develop, in the long term, a robot based on the best features lizards show when moving in a granular environment.

“Through this project, we expect to define the optimal conditions: the dimensions, elasticity, frequency and amplitude of vibrations to move forward in waves through a granular environment,” the researcher said.

The relationship between lizards and the development of robots is not odd; on the contrary, it can benefit technological development and improve people´s quality of life. For example, it can be used in critical situations.

“With regard to its applications, developing robots able to efficiently move in granular environments could help to detect anti-personnel mines in the deserts and find people trapped under avalanches,” Dr Darbois concluded.

Translated by Marcela Contreras

• A research team at the Faculty of Chemistry and Biology led by Dr Claudia Ortiz Calderón developed a device based on Chilean brown algae and pumice stone, which is able to adsorb copper from copper-bearing solutions produced by mining industry.

A research team at the Faculty of Chemistry and Biology led by Dr Claudia Ortiz Calderón developed a device based on Chilean brown algae and pumice stone, which is able to adsorb copper from copper-bearing solutions produced by mining industry.

Dr Ortiz, who is in charge of the Laboratory of Vegetable Biochemistry and Phytoremediation of the university, says that this study is part of the research that they usually conduct on the use of plants for environmental remediation.

Using this new device, it is possible to adsorb copper from copper-bearing streams to recover ions and send them back to the mining process, and clean the waters to use them again. Dr Ortiz says that they are already studying the effectiveness of the bio-filter with other metals, what could attract the interest of different companies.

Basically, the bio-filter is a vertical-flow column that contains three types of brown algae – which are very common in the Chilean coast- and pumice stone arranged in a way that is able to capture copper.

“First, we collect the algae and then, after washing, drying, chopping and screening them to a specific size, we package them together with pumicite or pumice stone that prevents the algae from getting compressed,” Dr Ortiz says.

She emphasizes that, in order no produce the bio-filter, they do not require to collect living biomass or to harvest algae. As they use waste algae and do not pre-treat the biomass, the bio-filter has a low cost of production. 

Patent request

The project started in 2012 and was funded by Corfo (the Chilean Economic Development Agent). It is currently at a protection stage after filing a patent request for the packaging system.

The next step is to continue with the analyses to determine the effectiveness of the bio-filter with other metals.

“We know that the bio-filter works very well for copper and we have also tested other equivalent cations, like zinc, cobalt and cadmium, and they have usually worked quite well too,” Dr Ortiz says.

“Thus, companies or industrial processes generating these elements which are interested in removing or recycling them could also be interested in the filter.”

In this context, the Canadian company Good Harbor that supported the project by conducting the hydraulic study of the columns has already expressed its interest in acquiring the rights of this new product.

Translated by Marcela Contreras

• The Food Science and Technology Research Center of Universidad de Santiago was awarded a public bid called by Junaeb to evaluate the quality and safety of food rations provided by schools at the Metropolitan Region. According to Claudio Martínez, the Director of the Center, “this shows that our accredited laboratories and our professionals are able to face challenges that involve high responsibilities.”

In December 2013, the laboratories of the Food Science and Technology Research Center of Universidad de Santiago (CECTA; in Spanish) were accredited by the National Institute for Standardization.

On August 1st, for the first time after this official certification, CECTA was awarded an important bid called by the National Board of Student Aid and Scholarships (Junaeb, in Spanish). As a result of this, CECTA will be in charge of analyzing the meals that are daily delivered to public schools, preschools and nursery schools in the Metropolitan Region.

Katy Yáñez, the Chief of the Physical and Chemical Analysis Laboratory and project leader, explained that samples of the food rations served for breakfast and lunch at 55 educational establishments of the Metropolitan Region and samples of 40 raw- material storage facilities will be analyzed over three months.

“At our Microbiology Laboratory and Physical and Chemical Analysis Laboratory (both with ISO 17025 accreditation), and together with an external laboratory that was subcontracted for the sample collection work, we will analyze the samples collected from food suppliers and schools in order to establish if these foods have the nutritional value and calories required and, in general, if they meet the microbiological parameters set by Junaeb,” she said.

A higher challenge

According to Claudio Martínez, Director of CECTA, the fact of being awarded this public bid called by Junaeb is “an important step for our University and for our Center, because, just to bid on this tender, being accredited as a high-scientific standard laboratory was required.”

“For a long time, CECTA has been working in strengthening its professional quality by implementing relevant policies and developing several improvements. Therefore, having been awarded this bid shows that our accredited laboratories and our professionals are able to face higher challenges that involve high responsibilities,” CECTA’s Director pointed out, adding that the following step “is just doing the high-quality scientific work that characterizes us.”


Translated by Marcela Contreras

• The Regular Fondecyt Project “Mapping underlying genetic variants in nitrogen assimilation in different natural yeasts” led by Dr Claudio Martínez, researcher at the Food Science and Technology Research Center of Universidad de Santiago, proposes a new wine fermentation method that will not depend on nitrogen levels in the must. The study will last until 2019 and it involves the participation of researchers at the Department of Food Science and Technology of Universidad de Santiago and foreign experts from the CNRS in Nice (France) and the Instituto de Agroquímica y Tecnología de Alimentos in Valencia (Spain).

​

Yeasts are essential for wine fermentation as they turn grape sugar into alcohol. However, current industrial yeasts do not guarantee the completion of the fermentation process, resulting in economic losses for the national wine-making industry.

“It is estimated that about 40 per cent of the fermentation processes are interrupted, with a very strong impact on the industry. If you interrupt the process, thousands of litres will not ferment, so you need to spend more money to complete the process by adding more yeast or nutrients. This affects the wine properties and the quality expected,” Dr Claudio Martínez, director of the Food Science and Technology Research Center of Universidad de Santiago (Cecta, in Spanish), said.

To solve this problem, Dr Martínez and researchers at Universidad de Santiago are currently conducting the Regular Fondecyt Project “Mapping underlying genetic variants in nitrogen assimilation in different natural yeasts,” that will last until 2019.

“For yeasts to develop and work well, the abundant presence of some nutrients, like nitrogen, is required. As some musts have low levels of nitrogen, yeasts there do not grow well and the resulting product is not good. We will study the genes of Chilean native yeasts and foreign yeasts, searching for the ones that allow the yeast to assimilate nitrogen without considering its levels, and ferment the must efficiently,” he explained.

The yeasts described have been collected by the researchers at Cecta during the past decade, what allowed obtaining the most complete yeast strain collection of the country. With this register and through a previous Fondef Project, the Cecta developed a yeast strain, Fermicru XL, which has already been patented and commercialized worldwide.

“This new study has the purpose of identifying the genes with the features previously described to genetically improve industrial yeasts, something that has not been done before in Chile. First, we will search for the genes with the features we want in native yeasts and then, we will enhance an industrial strain, without using transgenic techniques,” he said.

The project will have the collaboration of Dr Amparo Querol of the Instituto de Agroquímica y Tecnología de Alimentos (IATA), in Valencia, Spain and Dr Gianni Liti, of the National Center for Scientific Research, (CNRS, in French), in Nice, France. Both centers will work on the genetic enhancement of yeast and the development of procedures for genetic investigation. Besides, they will allow access to their own collections of yeast native strains.

“They have yeast strains that they have collected from all over the world, representing more than 70 per cent of the world’s genetic varieties of yeasts. This is a very important genetic source that we will have available when conducting our study,” he added.

Dr Angélica Ganga, professor at the Department of Food Science and Technology; Dr Francisco Cubillos, researcher at Cecta; Dr Álvaro Díaz, of Universidad Católica de Valparaíso; and Dr Cristián Araneda, of Universidad de Chile, will also be part of the research team.

“It is important to study native yeasts. We assume that they have adapted to some environmental factors, so their properties can be potential solutions for the industry. This opportunity to study them allows us to progress in solving some issues, to develop genetic enhancement, and if everything goes as expected, to patent future yeasts based on native strains of our country,” Dr Martínez concluded.

Translated by Marcela Contreras

• The new therapy involves the development of a vaccine that provides the immune system with the tools needed to “attack” cancer cells, improving the antitumour response of the body. The therapy was announced to foreign media correspondents accredited in Chile.

• The study is funded through a Fondecyt Project and it is at preclinical stage. It considers a significant decrease of more than 70% in the overall cost of therapies for this disease.
• The leader of the project, Claudio Acuña, Dr in Biomedical Sciences, researcher, and Head of the Department of Biology of our University, gave us some details on this new technology, which is applying for a patent in USA with the support of Corfo.
• Dr Acuña said: “We are generating a quite effective therapy for cancer through which we could make immunotherapy more available to people. We are doing this in a university which is known for its social responsibility signature. In this context, I would like to highlight the talent of my students involved in this project.”

In order to optimize cancer therapy and contribute to public health in our country, an innovative and significant treatment developed at Universidad de Santiago has recently been presented.

This project involves the development of a vaccine that will allow destroying cancer cells in the body by enhancing its immune response.

This scientific development- funded by the National Fund for Scientific and Technological Development, Fondecyt- considers a significant decrease of more than 70% in the overall costs of cancer therapies and it has shown an efficacy of 50%.

Dr Claudio Acuña, Head of the Department of Biology of Universidad de Santiago, is leading the project. “We want to have a vaccine available to protect us from the disease, just like in the vaccination process for measles and other diseases when we are children. In the case of cancer, our idea is to get people vaccinated so that they are able to eliminate cancer cell in their bodies, he said.”

Quality of life

According to the researcher, the project “Seeks to improve the quality of life of patients in the long term and generate a supplementary therapy to conventional treatments to resist cancer in a non-conventional way, which is currently treated with chemotherapy.”

“We have completed the preclinical stage (trials in living animals) which showed that the vaccine does protect from the disease. The next step is the clinical phase, in which it will be tested in human subjects. There was not any negative effect on animals, so we could extrapolate that there will be not any effect on patients,” he added.

“The ultimate goal is to generate a vaccine for people with cancer that will allow enhancing their immune response to tumours,” he said.

“We are generating a quite effective therapy for cancer in which we could make immunotherapy more available to people. We are doing this in a university which is known for its social responsibility signature. In this context, I would like to highlight the talent of my students involved in this project,” the scientist said.

“We were able to make it because the University enables, favours and promotes these innovation processes, besides providing the confidence to conduct high-level research,” he added.

Dicyt project

Dr Acuña’s meeting with foreign media correspondents was in the context of the activities of a Dicyt Public Opinion Project of Universidad de Santiago, led by Gabriela Martínez Cuevas, professor at the Department of Journalism.

Professor Martínez highlighted the interest of Fundación Imagen de Chile in contributing to promote the significance of this study among a group of accredited correspondents in Chile.

“Due to the strategic partnership that we developed with Fundación Imagen de Chile last year in a similar project, we have been able to arrange the first of a series of conferences with foreign accredited correspondents, during 2015,” professor Martínez said.

“This body has the purpose of managing the “nation branding”, so we have joined efforts to strengthen our “U de Santiago brand” around the world through our scientists,” she added.

Gabriela Martínez, who is also Director of the Communications Department and the institutional radio station said: “Today, the interest of the international press for learning about this study led by Dr Claudio Acuña was evident, and he insisted on the importance of the contribution made by the young researchers that he is training.”

She said: “There were correspondents of all the agencies in Europe, China and Latin America. We expect to see how they inform the world about this new contribution made by our state and public University, which is committed to the country progress and gives solutions to urgent demands beyond our borders. This was specifically demonstrated with this cancer vaccine.”

The project- which is at its preclinical stage- is based on effects of Polymixin B. It has already shown its first results in lymphoma, melanoma and breast, with an effectiveness of almost 50%. Besides, it is worth to mention that this technology could decrease the cost of current traditional cancer therapies by up to 70%.

With the support of the Chilean Economic Development Agency (Corfo, in Spanish), this technology is in the patenting process both in Chile and USA, to then continue to the clinical stage and to exporting the treatment.

Fundación Imagen de Chile

According to its web page, Fundación Imagen de Chile is an autonomous institution funded by public resources, created in 2009, with the purpose of coordinating and organizing the efforts to promote the image of Chile abroad.

Its responsibility is to mange the “nation branding”, by coordinating the work of the main sectors that contribute to build this image, such as culture, sports, exportations, investments, tourism and international relations, among others. For this purpose, the foundation develops strategic partnerships with public and private agents to coordinate the image of the country and actively position the distinctive features of our identity.

Translated by Marcela Contreras